Need a mobile version?

ASCLS eNewsBytes
July 7, 2009
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Patients Not Always Told of Lab Results
from Medscape Medical News
Primary care clinicians and their staffs sometimes fail to inform all patients of the results of lab or screening tests – or fail to keep records that patients were informed and thus have no proof, says a study in the June 22 issue of the Archives of Internal Medicine. That poses potential dangers to consumer health and possible legal troubles for doctors, researchers say. More    E-mail article

Beckman Coulter

U.S. Doctors Treat Heart Attack with Man's Own Stem Cells
from HealthDay News via Forbes
American physicians say they've performed the first procedure in which a patient received injections of his own heart stem cells to repair heart attack damage. The 39-year-old man is the first of 16 people who will undergo the procedure as part of a phase 1 clinical trial being conducted at Cedars-Sinai Heart Institute in Los Angeles. Another eight people will act as controls. More    E-mail article

Variations in Five Genes Raise Risk for Most Common Brain Tumors
from Science Daily
Common genetic variations spread across five genes raise a person's risk of developing the most frequent type of brain tumor, an international research team reports online in Nature Genetics. Genetic risk factors identified by the research team, also are the first glioma risk factors of any type identified in a large study. More    E-mail article

Using Hemoglobin A1c Values to Diagnose Diabetes
from Medscape Medical News
Anne L. Peters, MD, CDE, director of clinical diabetes programs at the University of Southern California and professor of clinical medicine at the university's Keck School of Medicine, discusses using Hemoglobin A1c values to diagnose diabetes. More    E-mail article

Arteriocyte Medical Systems in Cleveland Works on Machine to Produce Large Quantities of Artificial Blood
from The Plain Dealer
Lab results at a small biotechnology firm in Cleveland show early promise for creating a machine that can produce large quantities of pre-packaged artificial blood. But researchers expect the technology will not be ready for use for at least a couple of years. The team at Arteriocyte Medical Systems claims to have successfully created human blood from stem cells at a rate that could allow the military and hospitals to produce units of blood on site. More    E-mail article


Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice
from Science magazine
Recent reports of mild to severe influenza-like illness in humans caused by a novel swine-origin 2009 A(H1N1) influenza virus underscore the need to better understand the pathogenesis and transmission of these viruses in mammals. Here, selected 2009 A(H1N1) isolates were assessed for their ability to cause disease in mice and ferrets, and compared with a contemporary seasonal H1N1 virus for their ability to transmit by respiratory droplets to naïve ferrets. More    E-mail article

Washington to Give Antiviral Drugs to WHO
from Reuters
The U.S. government said it will give 420,000 treatment courses of Tamiflu to the Pan-American Health Organization to help fight the new H1N1 influenza virus in Latin America and the Caribbean. The U.S. Health and Human Services Department said treating and preventing the virus helps the security of the region, as well as that of the United States. More    E-mail article

Is ViraCor-IBT Labs Merger a Redux of the LabCorp-Monogram Deal?
from GenomeWeb Daily News
ViraCor Laboratories, a clinical lab specializing in infectious diseases, plans to merge with IBT Laboratories, a clinical-diagnostics and biomedical-research lab specializing in immunology and allergy assays, the firms said. The short take-home on the deal is that, with IBT on board, ViraCor gets a ready-made R&D shop that develops novel immunology and infectious-disease assays for clinical labs. More    E-mail article

Infectious Disease Experts Applaud Move to Overturn HIV Entry Ban
from Infection Control Today
The Infectious Diseases Society of America, the HIV Medicine Association, and the Center for Global Health Policy say they strongly support the Obama administration’s move to lift the two-decades-old ban on travel and immigration to the U.S. by HIV-positive individuals. More    E-mail article

Stem Cell Factor Indicative of Asthma Severity
from U.S. News & World Reports
In 25 or 50 or 75 years, maybe today's scourges — cancer, heart disease, diabetes — will have receded into medical lore as 21st-century versions of childbirth fever (it once killed a quarter of the women who delivered at some hospitals) or tuberculosis. If so, thanks will be owed to medical pioneers like the 14 you can read about here — smart, imaginative, and impatient with conventional boundaries. Such cutting-edge scientists are also increasingly well funded, thanks to the new emphasis by the White House and Congress on research. More    E-mail article

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Ben Maitland, Director of Advertising Sales

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • Aug. 11, 2009
  • Aug. 4, 2009
  • July 28, 2009
  • July 21, 2009
  • July 14, 2009

     RSS Feed
    Most popular articles

  • 7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063